Switch theme
Sign up to access all valuation multiples
Perpetua Medical AB is engaged in healthcare sector. The company develops systems and solutions that plan to optimize and ensure correct and effective treatment with injectable drugs. Its products include WasteLog and Pharmacolog Dashboard.
2007
11
Last FY Revenue $0.7M
Last FY EBITDA -$0.2M
$1.9M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Perpetua Medical achieved revenue of $0.7M and an EBITDA of -$0.2M.
Perpetua Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Perpetua Medical valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $0.7M | XXX | XXX | XXX |
| Gross Profit | XXX | $0.3M | XXX | XXX | XXX |
| Gross Margin | XXX | 45% | XXX | XXX | XXX |
| EBITDA | XXX | -$0.2M | XXX | XXX | XXX |
| EBITDA Margin | XXX | -26% | XXX | XXX | XXX |
| EBIT | XXX | -$0.3M | XXX | XXX | XXX |
| EBIT Margin | XXX | -35% | XXX | XXX | XXX |
| Net Profit | XXX | -$0.3M | XXX | XXX | XXX |
| Net Margin | XXX | -36% | XXX | XXX | XXX |
| Net Debt | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Perpetua Medical's stock price is SEK 5 (or $0).
Perpetua Medical has current market cap of SEK 21.4M (or $2.2M), and EV of SEK 18.2M (or $1.9M).
See Perpetua Medical trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.9M | $2.2M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Perpetua Medical has market cap of $2.2M and EV of $1.9M.
Perpetua Medical's trades at 2.6x EV/Revenue multiple, and -10.1x EV/EBITDA.
Equity research analysts estimate Perpetua Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Perpetua Medical's P/E ratio is not available.
See valuation multiples for Perpetua Medical and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2.2M | XXX | $2.2M | XXX | XXX | XXX |
| EV (current) | $1.9M | XXX | $1.9M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 2.6x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | -10.1x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | -7.4x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | -8.7x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -2.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialPerpetua Medical's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.
Perpetua Medical's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Perpetua Medical's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Perpetua Medical and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | -26% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 81% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Perpetua Medical acquired XXX companies to date.
Last acquisition by Perpetua Medical was XXXXXXXX, XXXXX XXXXX XXXXXX . Perpetua Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Perpetua Medical founded? | Perpetua Medical was founded in 2007. |
| Where is Perpetua Medical headquartered? | Perpetua Medical is headquartered in Sweden. |
| How many employees does Perpetua Medical have? | As of today, Perpetua Medical has 11 employees. |
| Is Perpetua Medical publicy listed? | Yes, Perpetua Medical is a public company listed on STO. |
| What is the stock symbol of Perpetua Medical? | Perpetua Medical trades under PERP B ticker. |
| When did Perpetua Medical go public? | Perpetua Medical went public in 2015. |
| Who are competitors of Perpetua Medical? | Similar companies to Perpetua Medical include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Perpetua Medical? | Perpetua Medical's current market cap is $2.2M |
| Is Perpetua Medical profitable? | Yes, Perpetua Medical is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
